Sculptor Capital’s Herbalife HLF Stock Holding History

Sculptor Capital’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,200,500	Closed	-$130M	–	244
2018 Q4	$130M	Hold	2,200,500	–	–	0.85%	25
2018 Q3	$120M	Hold	2,200,500	–	–	0.66%	30
2018 Q2	$118M	Buy	+2,200,500	New	+$116M	0.55%	30
2017 Q4	–	Sell	-2,175,600	Closed	-$73.8M	–	87
2017 Q3	$73.8M	Hold	2,175,600	–	–	0.36%	56
2017 Q2	$77.6M	Buy	2,175,600 +51,800	+2%	+$1.75M	0.41%	61
2017 Q1	$61.7M	Buy	2,123,800 +1,232,400	+138%	+$34.3M	0.35%	67
2016 Q4	$21.5M	Buy	891,400 +879,400	+7,328%	+$24M	0.15%	106
2016 Q3	$372K	Buy	+12,000	New	+$379K	﹤0.01%	270
2015 Q1	–	Sell	-283,400	Closed	-$5.34M	–	580
2014 Q4	$5.34M	Hold	283,400	–	–	0.01%	452
2014 Q3	$6.2M	Buy	283,400 +131,000	+86%	+$3.5M	0.02%	473
2014 Q2	$4.92M	Sell	152,400 -1,800	-1%	-$55.2K	0.01%	519
2014 Q1	$4.42M	Sell	154,200 -41,000	-21%	-$1.35M	0.01%	516
2013 Q4	$7.68M	Hold	195,200	–	–	0.02%	499
2013 Q3	$6.81M	Buy	195,200 +98,000	+101%	+$3.03M	0.02%	499
2013 Q2	$2.19M	Buy	+97,200	New	+$2.07M	0.01%	563

Other funds holding HLF

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DVI

Deccan Value Investors Greenwich, Connecticut $84.6M AUM 57.32% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Sculptor Capital's HLF Position: Q4 2017 in Review

Sculptor Capital sold out of Herbalife (HLF) in Q4 2017, closing a stake of 257,454 shares — an estimated $8.73M sold.

Sculptor Capital first reported a position in HLF in Q2 2013 and held it in 9 quarters. The position peaked at $12.7M in Q2 2017. 203 funds tracked by Wall St. Rank hold HLF as of Q4 2017.

Sculptor Capital reported no remaining Herbalife position as of Q4 2017 after selling out during the quarter.
Sculptor Capital sold 257,454 Herbalife shares in Q4 2017, an estimated $8.73M.
Sculptor Capital first reported a position in Herbalife in Q2 2013 and held it in 9 quarters.
Sculptor Capital's Herbalife position peaked at $12.7M in Q2 2017.
203 funds tracked by Wall St. Rank held Herbalife as of Q4 2017.

Based on Sculptor Capital's 13F filing for Q4 2017, filed 13 Feb 2018.